1. Home
  2. VIVS vs BOXL Comparison

VIVS vs BOXL Comparison

Compare VIVS & BOXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIVS
  • BOXL
  • Stock Information
  • Founded
  • VIVS 2007
  • BOXL 1985
  • Country
  • VIVS United States
  • BOXL United States
  • Employees
  • VIVS N/A
  • BOXL N/A
  • Industry
  • VIVS Biotechnology: Biological Products (No Diagnostic Substances)
  • BOXL Telecommunications Equipment
  • Sector
  • VIVS Health Care
  • BOXL Telecommunications
  • Exchange
  • VIVS Nasdaq
  • BOXL Nasdaq
  • Market Cap
  • VIVS 4.7M
  • BOXL 4.9M
  • IPO Year
  • VIVS N/A
  • BOXL 2017
  • Fundamental
  • Price
  • VIVS $3.64
  • BOXL $1.65
  • Analyst Decision
  • VIVS
  • BOXL Buy
  • Analyst Count
  • VIVS 0
  • BOXL 3
  • Target Price
  • VIVS N/A
  • BOXL $5.00
  • AVG Volume (30 Days)
  • VIVS 868.7K
  • BOXL 2.3M
  • Earning Date
  • VIVS 11-07-2025
  • BOXL 11-12-2025
  • Dividend Yield
  • VIVS N/A
  • BOXL N/A
  • EPS Growth
  • VIVS N/A
  • BOXL N/A
  • EPS
  • VIVS N/A
  • BOXL N/A
  • Revenue
  • VIVS $142,000.00
  • BOXL $113,560,000.00
  • Revenue This Year
  • VIVS $42.38
  • BOXL N/A
  • Revenue Next Year
  • VIVS $15.42
  • BOXL N/A
  • P/E Ratio
  • VIVS N/A
  • BOXL N/A
  • Revenue Growth
  • VIVS 94.52
  • BOXL N/A
  • 52 Week Low
  • VIVS $1.41
  • BOXL $1.06
  • 52 Week High
  • VIVS $21.96
  • BOXL $10.65
  • Technical
  • Relative Strength Index (RSI)
  • VIVS 62.00
  • BOXL 45.09
  • Support Level
  • VIVS $3.29
  • BOXL $1.63
  • Resistance Level
  • VIVS $5.30
  • BOXL $3.25
  • Average True Range (ATR)
  • VIVS 0.63
  • BOXL 0.20
  • MACD
  • VIVS 0.16
  • BOXL 0.03
  • Stochastic Oscillator
  • VIVS 52.16
  • BOXL 1.23

About VIVS VivoSim Labs Inc. Common Stock

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.

Share on Social Networks: